Physician profile
Nicolas Rich, JR.
NPI 1689741712
$2,032.49
in general payments reported to CMS, 2019-2025
17 companies · $225 in 2025
The $225 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $140 · 2021: $312 · 2022: $309 · 2023: $334 · 2024: $360 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $648.43 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $561.33 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $147.53 | 2019-2025 | |
| Inspire Medical Systems, INC. | $103.85 | 2023 | Inspire |
| Corium, LLC | $89.00 | 2023-2024 | Azstarys |
| Pfizer INC. | $80.83 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.39 | 2019-2022 | |
| Seqirus USA INC | $56.30 | 2022-2025 | Flucelvax |
| Tris Pharma INC | $52.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $46.12 | 2023-2024 | Flumist Quadrivalent |
| Genentech USA, INC. | $45.74 | 2020-2022 | |
| Cumberland Pharmaceuticals, INC. | $29.79 | 2024-2025 | Kristalose |
| Collegium Pharmaceutical, INC. | $23.10 | 2025 | Jornay Pm |
| Krystal Biotech INC | $21.76 | 2025 | Vyjuvek |
| Ironshore Pharmaceuticals INC. | $19.13 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $18.14 | 2019 | |
| Incyte Corporation | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.